Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,110.4
39.3 (1.28%)

 

  • STI Straits Times Index
    3,110.4
    39.3 (1.28%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,624.2
    12.4 (0.77%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,924.9
    384.1 (1.35%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,415.2
    -6.2 (-0.18%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,015.4
    272.2 (0.95%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,239.2
    -9.2 (-0.15%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 944.5M
  • Value: 1,038.2M
  • Rise: 158
  • Fall: 113
  • Unch: 504

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.038-0.005
Sembcorp Marine0.161+0.001
CWX Global0.006+0.001
Jiutian Chemical0.082+0.002
Shen Yao0.004-
FJ Benjamin0.046+0.002
3Cnergy0.020+0.002
Enviro-Hub0.076+0.003
ComfortDelGro1.700+0.060
YZJ Shipbldg SGD1.100-0.010

World Indices

World Indices
Name Last Change
Nasdaq 12,609.2 -311.0
HSI 28,924.9 +384.1
HSCEI 11,083.6 +68.8
Jakarta 6,236.8 -11.7
Nikkei 225 28,916.3 +173.0
SSE Comp 3,415.2 -6.2
Shanghai A 3,579.8 -6.5
Shanghai B 242.1 +0.9
KOSPI 2,967.7 -28.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CARDIFF ONCOLOGY INC CARDIFF ONCOLOGY
Updated on 08 Mar 2021 (End of trading day)
Last (USD): 9.150 Change: -0.570 High: 9.900 Remarks: -
Change (%): -5.86 Low: 9.115
Open 9.830 Yesterday's Close 9.72
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 705,631 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.60988 Trailing EPS (USD) e -0.60988 NAV (USD) b 3.5174
PE a - Trailing PE f - Price / NAV b 2.6014
Dividend (USD) d - Cash In Hand (USD) g 3.5350 Issued & Paid-up Shares c 37,052,100
Dividend Yield (%) d - Price / Cash In Hand g 2.588 Treasury Shares h -
Market Cap (M) 339.027 Enterprise Value (M) 208.915
Piotroski F Score 3 Exchange Code CRDF Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 91.0
Sector & Industry Health Services - Medical/Nursing Services
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 26 Feb 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 08 May 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CARDIFF ONCOLOGY INC NASDAQ 339.027 - - 2.6014 -
Industry Medical/Nursing Services NASDAQ 2,198.907 - - 6.9114 0.014
Local Peer GUARDANT HEALTH INC NASDAQ 12,837.583 - - 9.8865 -
Local Peer NATERA INC NASDAQ 8,042.019 - - 16.5393 -
Local Peer AMEDISYS INC NASDAQ 8,029.159 43.730 43.730 9.9221 -
Local Peer LHC GROUP INC NASDAQ 5,587.136 50.066 50.066 3.6547 -
Local Peer 1LIFE HEALTHCARE INC NASDAQ 5,140.865 - - 9.3731 -
Local Peer NEOGENOMICS INC NASDAQ 4,860.026 1,164.798 1,164.915 6.9999 -
Local Peer ACADIA HEALTHCARE NASDAQ 5,056.576 25.906 25.906 2.6621 -
Local Peer ENSIGN GROUP INC NASDAQ 4,553.417 26.710 26.710 5.5660 0.243
Local Peer SMILEDIRECTCLUB INC NASDAQ 4,048.822 - - 13.1427 -
Local Peer OPTION CARE HEALTH INC NASDAQ 3,347.783 - - 3.3697 -
Local Peer BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A NASDAQ 2,871.126 - - 7.7211 -
Local Peer FULGENT GENETICS INC NASDAQ 2,295.312 10.497 10.497 4.0312 -
Other Local Peers GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), ADDUS HOMECARE CORP (NASDAQ), PENNANT GROUP INC (NASDAQ), TIVITY HEALTH INC (NASDAQ), RADNET INC (NASDAQ), APRIA INC (NASDAQ), BIODESIX INC (NASDAQ), ONTRAK INC (NASDAQ), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), AKUMIN INC (NASDAQ), EXAGEN INC (NASDAQ), PROGENITY INC (NASDAQ), SANARA MEDTECH INC (NASDAQ), APTINYX INC (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), OPTINOSE INC (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), PRO-DEX INC (NASDAQ), NOVO INTEGRATED SCIENCES INC (NASDAQ), GBS INC (NASDAQ), BIOCEPT INC (NASDAQ), GUARDION HEALTH SCIENCES INC (NASDAQ), IMAC HOLDINGS INC (NASDAQ)
Global Peer JD HEALTH HKEx 369,705.357 - - -57.8677 -
Global Peer FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV NYSE 20,325.872 15.414 15.414 1.4812 -
Global Peer PA GOODDOCTOR HKEx 110,426.663 - - 5.8824 -
Global Peer OAK STREET HEALTH INC NYSE 12,712.022 - - 27.6165 -
Global Peer DAVITA INC NYSE 11,772.534 15.029 15.030 8.5088 -
Global Peer SONIC HEALTHCARE ASX 14,826.754 28.094 15.591 2.5435 2.724
Global Peer CHEMED CORP NYSE 6,907.615 21.622 21.622 7.6649 0.304
Global Peer INVITAE CORP NYSE 6,835.728 - - 3.4589 -
Global Peer JXR HKEx 37,522.950 80.785 95.066 4.5227 0.439
Global Peer NH HEALTH-B HKEx 22,569.354 - - -23.5962 -
Other Global Peers MEDNAX INC (NYSE), HEALIUS LTD (ASX), US PHYSICAL THERAPY (NYSE), SVH (SET), RAM (SET), KPJ (Bursa), HANGER INC (NYSE), UM HEALTHCARE (HKEx), C-MER EYE (HKEx), Metro Healthcare Indonesia Tbk. (IDX), OCEANIA HEALTHCARE LTD (ASX), GLOBAL CORD BLOOD CORPORATION (NYSE), TOWN HEALTH (HKEx), VIRTUS HEALTH LIMITED (ASX), EUROEYES (HKEx), CRH MEDICAL CORP (NYSE American), BARD1 LIFE SCIENCES LTD (ASX), SILK LASER AUSTRALIA LTD (ASX), CLOVER CORP (ASX), KANGHUA HEALTH (HKEx), HEALTHIA LTD (ASX), RAILY AESMED (HKEx), OPTIMAX (Bursa), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), UMP (HKEx), Cordlife (SGX), ORTHOCELL LIMITED (ASX), Clearbridge (SGX), Asian Healthcare (SGX), CAPITAL SENIOR LIVING CORP (NYSE), MHCARE (Bursa), KDH (SET), HC Surgical (SGX), Diagnos Laboratorium Utama Tbk. (IDX), HUMAN HEALTH (HKEx), D (SET), Sing Paincare (SGX), CHINA HEALTH (HKEx), Alliance HC (SGX), TOTAL BRAIN LTD (ASX), Medinex (SGX), AsiaMedic (SGX), LIFESPOT HEALTH LTD (ASX), SMILE (Bursa), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), RHT HealthTrust (SGX), REPUBLIC HC (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX), TOPVISN (Bursa)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --1.950
-17.57 %
10 Days --1.120
-10.91 %
20 Days --3.860
-29.67 %
Medium Term Return 3 Months --11.510
-55.71 %
6 Months -+3.450
+60.53 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.825 - 25.500 Change From 1 Year Low +8.325 % Change From 1 Year Low (%) +1009.09
Change From 1 Year High -16.350 % Change From 1 Year High (%) -64.12
2 Years Range 0.825 - 25.500 Change From 2 Years Low +8.325 % Change From 2 Years Low (%) +1009.09
Change From 2 Years High -16.350 % Change From 2 Years High (%) -64.12
5 Years Range 0.825 - 25.500 Change From 5 Years Low +8.325 % Change From 5 Years Low (%) +1009.09
Change From 5 Years High -16.350 % Change From 5 Years High (%) -64.12
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. The firm's clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.

Historical Price Data

Date Open High Low Close Volume VWAP
08 Mar 2021 9.830 9.900 9.115 9.150 705,631 -
05 Mar 2021 9.340 9.810 8.120 9.720 1,521,453 -
04 Mar 2021 10.025 10.220 9.040 9.180 1,395,853 -
03 Mar 2021 11.070 11.230 10.010 10.110 1,085,487 -
02 Mar 2021 10.770 11.440 10.725 11.100 965,356 -
01 Mar 2021 10.630 10.830 10.040 10.740 765,750 -
26 Feb 2021 9.870 10.350 8.390 10.340 3,224,077 -
25 Feb 2021 10.250 10.470 9.600 9.750 1,255,442 -
24 Feb 2021 10.450 10.530 10.110 10.280 1,166,307 -
23 Feb 2021 10.860 10.930 9.910 10.270 1,362,010 -
22 Feb 2021 11.510 11.680 11.070 11.300 1,294,011 -
19 Feb 2021 11.900 12.300 11.560 11.670 1,034,057 -
18 Feb 2021 12.460 13.050 11.710 11.730 1,332,503 -
17 Feb 2021 12.938 13.140 12.350 12.770 1,713,366 -
16 Feb 2021 13.110 13.240 12.800 13.070 1,283,734 -
12 Feb 2021 14.100 14.200 12.890 13.030 2,090,268 -
11 Feb 2021 13.420 14.980 12.950 14.240 4,066,269 -
10 Feb 2021 13.160 13.579 12.610 13.000 1,261,485 -
09 Feb 2021 13.400 13.580 12.900 13.010 917,217 -
08 Feb 2021 13.100 13.800 12.871 13.520 1,238,844 -
05 Feb 2021 12.550 13.300 12.516 13.020 1,276,671 -
04 Feb 2021 13.560 13.790 12.200 12.550 2,993,393 -
Summary
Current 2 Weeks
(23 Feb 2021 to 08 Mar 2021)
10.860 11.440 8.120 9.150 13,447,366 -
Previous 2 Weeks
(08 Feb 2021 to 22 Feb 2021)
13.100 13.800 8.120 11.300 16,231,754 -
4 Weeks from
(08 Jan 2021 to 05 Feb 2021)
18.540 19.310 8.120 13.020 65,462,116 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.